Oorsprong van het eerstegraads netwerk van Michael Watson
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland.
15
| Non-Profit Organization | Medical/Nursing Services | 15 |
Osivax SAS
Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.
8
| Holding Company | Biotechnology | 8 |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA.
8
| Holding Company | Biotechnology | 8 |
VaxEquity Ltd.
VaxEquity Ltd. BiotechnologyHealth Technology VaxEquity Ltd. is a UK biotechnology company founded in 2020 by Professor Robin Shattock, the head of immunology of infection at Imperial College and Morningside. The company is based in Little Chesterford, UK. The British company is developing transformative RNA therapeutics and vaccines using its next-generation self-amplifying RNA platform called SARNA. The platform provides extended duration of protein expression, enabling lower doses to be used for vaccines and higher protein levels to be achieved for therapeutics. VaxEquity is pioneering a next-generation approach by modifying its SARNA to modulate the innate immune response and thereby overcoming current limitations. The flexibility of the company's platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale.
1
| Holding Company | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael Watson via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
AGENUS INC. | Biotechnology | Director/Board Member | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
ProterixBio, Inc.
ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member Chairman | |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Director/Board Member | |
Serica Technologies, Inc.
Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Director/Board Member | |
Atreaon, Inc.
Atreaon, Inc. Pharmaceuticals: OtherHealth Technology Atreaon, Inc. develops proteins for diseases treatment. It operates as a pharmaceutical company that develops medicines for the treatment of arthritis. The company was founded on December 19, 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Other | Director/Board Member | |
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
2020, Inc.
2020, Inc. Medical/Nursing ServicesHealth Services 2020, Inc. offers eye care services. It also offers delivers on-site eye care and eye exams to businesses and their employees via a mobile eye clinic. The company was founded by Howard Bornstein in 2013 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member | |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Biotechnology | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
ALLIANZ TECHNOLOGY TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
University of Oxford | College/University | Doctorate Degree | |
LumiCyte, Inc.
LumiCyte, Inc. BiotechnologyHealth Technology LumiCyte, Inc. provides biotechnology services and offers biochips and information products to the pharmaceutical and biotechnology companies. The company also designs, manufactures, and distributes STS MALDI chips for mass spectrometry analysis of proteins and peptides. Its products are used for the identification and analysis of markers involved in disease processes. The company was founded by T. William Hutchens in 2003 and is headquartered in Fremont, CA | Biotechnology | Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Graduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
International Institute for Management Development | College/University | Masters Business Admin | |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
Cascade Fund Management Ltd. | Director/Board Member | ||
AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Paras Ltd.
Paras Ltd. Miscellaneous Commercial ServicesCommercial Services Paras Ltd. provides information management and strategy consultancy services to the energy sector. The company was founded by Hamish Angus Munro Wilson in 1993 and is headquartered in Abingdon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Advanced Cell Diagnostics, Inc.
Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
ADC Products (UK) Ltd.
ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder | |
Xenva Ltd.
Xenva Ltd. Miscellaneous Commercial ServicesCommercial Services Xenva Ltd. provides boutique management services. The company was founded on June 19, 1997 and is headquartered in Hampshire, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
NUCANA PLC | Biotechnology | Director/Board Member | |
Synchroneuron, Inc.
Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Major | Director/Board Member | |
Pradeyrol Développement
Pradeyrol Développement Financial ConglomeratesFinance Pradeyrol Développement SC operates as an investment holding company. It invests in the biotechnology sector and mainly on molecular diagnostics. The company was founded on August 16, 2007 and is headquartered in Paris, France. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Founder Director/Board Member | |
New York University School of Law | College/University | Graduate Degree | |
Tufts University School of Medicine | College/University | Doctorate Degree | |
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Director/Board Member | |
AMYLYX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Artugen Therapeutics Ltd.
Artugen Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Artugen Therapeutics Ltd. develops precision treatments for infections. The company was founded in 2015 and is headquartered in Concord, MA. | Pharmaceuticals: Generic | Director/Board Member | |
Canopy Education, Inc.
Canopy Education, Inc. Miscellaneous Commercial ServicesCommercial Services Canopy Education, Inc. engages in the operation of a mentorship, test preparation and college consulting firm. It offers college and elite application programs, college essay assistance, school list creation and subject tutoring services. The company was founded by Zack Perkins, Johan Zhang, Mohan Zhang, and Vinay Bhaskara in 2013 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
K-Gen, Inc.
K-Gen, Inc. Miscellaneous Commercial ServicesCommercial Services K-Gen, Inc. is an American biotechnology company. The private company is based in San Francisco. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 35 |
Verenigd Koninkrijk | 11 |
Zwitserland | 3 |
Frankrijk | 3 |
Ierland | 3 |
Sectoraal
Health Technology | 30 |
Consumer Services | 8 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 4 |
Operationeel
Director/Board Member | 166 |
Corporate Officer/Principal | 49 |
Chairman | 24 |
Founder | 18 |
Independent Dir/Board Member | 18 |
Sterkste connecties
Insiders | |
---|---|
Shobana Kamineni | 48 |
Daniel Camus | 31 |
Isaac Cheng | 25 |
Kenneth Kelley | 19 |
Mark Kessel | 18 |
Stephanie O'Brien | 18 |
Christopher Martin | 18 |
Tyrell J. Rivers | 17 |
William F. Daly | 15 |
Maunatlala Mehlape | 15 |
Hugues Wallemacq | 9 |
Alexandre Le Vert | 9 |
Marcel Tanner | 7 |
Christian Pradeyrol | 3 |
Carlos Morel | 2 |
- Beurs
- Insiders
- Michael Watson
- Bedrijfsconnecties